Related Experiment Video

Updated: Oct 11, 2025

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

3.9K

Possible Therapeutic Applications of Targeting STAP Proteins in Cancer

Tadashi Matsuda1, Kenji Oritani2

  • 1Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University.

Biological & Pharmaceutical Bulletin
|December 2, 2021
PubMed

Insights

Signal-transducing adaptor proteins (STAP-1, STAP-2) regulate key signaling pathways in cancer and immune responses. Targeting STAP proteins offers potential therapeutic strategies for cancer treatment.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Signal-transducing adaptor proteins (STAP) are crucial in cellular signaling.
  • STAP-1 and STAP-2 are key members of this protein family.
  • These proteins possess characteristic adaptor protein domains (Pleckstrin homology, SRC homology 2).

Purpose of the Study:

  • To review the roles of the STAP protein family in biological processes.
  • To explore the involvement of STAP proteins in tumorigenesis and inflammatory/immune responses.
  • To discuss the therapeutic potential of targeting STAP proteins in cancer.

Main Methods:

  • Literature review of STAP protein functions.
  • Analysis of STAP protein interactions with signaling molecules (e.g., IKK, BYK, STAT3, STAT5).
  • Examination of STAP protein regulatory mechanisms in intracellular signaling.

Main Results:

  • STAP proteins bind to various signaling molecules, influencing pathways.
  • They play significant roles in tumorigenesis and inflammatory/immune responses.
  • STAP proteins exhibit unique mechanisms for regulating critical signaling steps.

Conclusions:

  • The STAP family represents a novel class of signaling adaptors.
  • Targeting STAP proteins may offer new therapeutic avenues for cancer treatment.
  • Further research into STAP protein functions is warranted for clinical applications.
Keywords:
adaptor proteincancer cell growthsignal transductionsignal-transducing adaptor protein (STAP)tumorigenesis

More Related Videos

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

406
Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors08:45

Assessing Cellular Target Engagement by SHP2 PTPN11 Phosphatase Inhibitors

Published on: July 17, 2020

6.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
3.1K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K